241 related articles for article (PubMed ID: 11371125)
1. Immunohistochemical expression of molecular markers in an avian model: a potential model for preclinical evaluation of agents for ovarian cancer chemoprevention.
Rodríguez-Burford C; Barnes MN; Berry W; Partridge EE; Grizzle WE
Gynecol Oncol; 2001 Jun; 81(3):373-9. PubMed ID: 11371125
[TBL] [Abstract][Full Text] [Related]
2. CA125 expression in spontaneous ovarian adenocarcinomas from laying hens.
Jackson E; Anderson K; Ashwell C; Petitte J; Mozdziak PE
Gynecol Oncol; 2007 Jan; 104(1):192-8. PubMed ID: 16942793
[TBL] [Abstract][Full Text] [Related]
3. A pilot study of ovarian cancer chemoprevention using medroxyprogesterone acetate in an avian model of spontaneous ovarian carcinogenesis.
Barnes MN; Berry WD; Straughn JM; Kirby TO; Leath CA; Huh WK; Grizzle WE; Partridge EE
Gynecol Oncol; 2002 Oct; 87(1):57-63. PubMed ID: 12468343
[TBL] [Abstract][Full Text] [Related]
4. Ovarian tumor expression of an oviductal protein in the hen: a model for human serous ovarian adenocarcinoma.
Giles JR; Shivaprasad HL; Johnson PA
Gynecol Oncol; 2004 Dec; 95(3):530-3. PubMed ID: 15581958
[TBL] [Abstract][Full Text] [Related]
5. Rhesus macaque model for ovarian cancer chemoprevention.
Brewer M; Baze W; Hill L; Utzinger U; Wharton JT; Follen M; Khan-Dawood F; Satterfield W
Comp Med; 2001 Oct; 51(5):424-9. PubMed ID: 11924802
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical assessment of proliferation markers and altered gene expression in archival specimens of ovarian epithelial tumors.
Khalifa MA; Lacher DA; Lage JM; Mannel RS; Walker JL; Angros LH; Min KW
Cancer Detect Prev; 1997; 21(6):532-9. PubMed ID: 9398993
[TBL] [Abstract][Full Text] [Related]
7. [Characterization of two antigens OC41 D and OC41 E associated with ovarian carcinoma].
Cui H
Zhonghua Fu Chan Ke Za Zhi; 1993 May; 28(5):284-6, 314-5. PubMed ID: 8243148
[TBL] [Abstract][Full Text] [Related]
8. Significance of tyrosine kinase activity on malign transformation of ovarian tumors: a comparison between EGF-R and TGF-alpha.
Zeren T; Inan S; Seda Vatansever H; Ekerbicer N; Sayhan S
Acta Histochem; 2008; 110(3):256-63. PubMed ID: 18054376
[TBL] [Abstract][Full Text] [Related]
9. B7-H4 overexpression in ovarian tumors.
Tringler B; Liu W; Corral L; Torkko KC; Enomoto T; Davidson S; Lucia MS; Heinz DE; Papkoff J; Shroyer KR
Gynecol Oncol; 2006 Jan; 100(1):44-52. PubMed ID: 16256178
[TBL] [Abstract][Full Text] [Related]
10. Morphological and phenotypic characterization of a new established ovarian carcinoma cell line (OvBH-1).
Bar JK; Harlozińska A
Anticancer Res; 2000; 20(5A):2975-80. PubMed ID: 11062710
[TBL] [Abstract][Full Text] [Related]
11. Tumor-associated glycoprotein (TAG-72) in ovarian carcinomas defined by monoclonal antibody B72.3.
Thor A; Gorstein F; Ohuchi N; Szpak CA; Johnston WW; Schlom J
J Natl Cancer Inst; 1986 Jun; 76(6):995-1006. PubMed ID: 3520078
[TBL] [Abstract][Full Text] [Related]
12. Combined staining of TAG-72, MUC1, and CA125 improves labeling sensitivity in ovarian cancer: antigens for multi-targeted antibody-guided therapy.
Chauhan SC; Vinayek N; Maher DM; Bell MC; Dunham KA; Koch MD; Lio Y; Jaggi M
J Histochem Cytochem; 2007 Aug; 55(8):867-75. PubMed ID: 17478446
[TBL] [Abstract][Full Text] [Related]
13. Reactivity of monoclonal antibody F36/22 with human ovarian adenocarcinomas.
Croghan GA; Wingate MB; Gamarra M; Johnson E; Chu TM; Allen H; Valenzuela L; Tsukada Y; Papsidero LD
Cancer Res; 1984 May; 44(5):1954-62. PubMed ID: 6370421
[TBL] [Abstract][Full Text] [Related]
14. Ependymomas of the central nervous system and adult extra-axial ependymomas are morphologically and immunohistochemically distinct--a comparative study with assessment of ovarian carcinomas for expression of glial fibrillary acidic protein.
Idowu MO; Rosenblum MK; Wei XJ; Edgar MA; Soslow RA
Am J Surg Pathol; 2008 May; 32(5):710-8. PubMed ID: 18360284
[TBL] [Abstract][Full Text] [Related]
15. [Immunohistochemical study of new monoclonal antibodies--E29, 115D8 --to an epithelial membrane antigen (EMA) in ovarian tumors].
Fujimoto I; Fukuda K; Hang SP; Hasumi K; Masubuchi K; Osamura Y; Watanabe K
Gan No Rinsho; 1987 Nov; 33(14):1798-804. PubMed ID: 2826841
[TBL] [Abstract][Full Text] [Related]
16. Expression of MUC1 in primary and metastatic human epithelial ovarian cancer and its therapeutic significance.
Wang L; Ma J; Liu F; Yu Q; Chu G; Perkins AC; Li Y
Gynecol Oncol; 2007 Jun; 105(3):695-702. PubMed ID: 17368732
[TBL] [Abstract][Full Text] [Related]
17. [Immunohistochemical demonstration of CA 125, CA 19-9 and CEA in normal and pathologically changed adnexa].
Neunteufel W; Breitenecker G
Geburtshilfe Frauenheilkd; 1988 May; 48(5):334-7. PubMed ID: 3165079
[TBL] [Abstract][Full Text] [Related]
18. Immune modulator CD70 as a potential cisplatin resistance predictive marker in ovarian cancer.
Aggarwal S; He T; Fitzhugh W; Rosenthal K; Feild B; Heidbrink J; Mesmer D; Ruben SM; Moore PA
Gynecol Oncol; 2009 Dec; 115(3):430-7. PubMed ID: 19800108
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of alternative and traditional immunohistochemical markers for the distinction of ovarian sertoli cell tumor from endometrioid tumors and carcinoid tumor: A study of 160 cases.
Zhao C; Bratthauer GL; Barner R; Vang R
Am J Surg Pathol; 2007 Feb; 31(2):255-66. PubMed ID: 17255771
[TBL] [Abstract][Full Text] [Related]
20. Jejunal adenocarcinoma presenting as a primary ovarian carcinoma.
Kilic G; Abadi M
Gynecol Oncol; 2000 Aug; 78(2):255-8. PubMed ID: 10926813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
